Fifth Third Bancorp »

Dyne Therapeutics shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of Dyne Therapeutics (DYN) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in Dyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Dyne Therapeutics held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dyne Therapeutics by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $983k 54k 18.13

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding Dyne Therapeutics

T. Rowe Price Investment Management
Henderson Group
BlackRock
Vanguard Group
Atlas Venture Life Science Advisors
Orbis Allan Gray
State Street Corporation
FMR
Vanguard Capital Management
Fcpm Iii Services B.v.
Adage Capital Partners GP
Perceptive Advisors
TCG Crossover Management
Vanguard Portfolio Management
Vestal Point Capital

View all funds holding Dyne Therapeutics